STOCKWATCH
·
Pharmaceuticals
Acquisitions28 Mar 2025, 06:07 pm

Ipca Laboratories to Sell Formulations Manufacturing Facility for Rs. 36.90 Crores and Acquire Unichem Laboratories Ltd., Ireland for Rs. 4 Crores

AI Summary

Ipca Laboratories Ltd. has approved the sale of its formulations manufacturing facility at Tarapur, Palghar to M/s. V. S. International Pvt. Ltd. for a consideration of Rs. 36.90 crores. The sale will not impact the company's business as the products can be manufactured in other facilities. The company also plans to acquire 100% share capital of Unichem Laboratories Ltd., Ireland from Unichem Laboratories Ltd., India for a consideration of Rs. 4 Crores. Unichem Ireland was incorporated to hold registration of formulation product dossiers in Europe and market/distribute the registered formulations manufactured by Unichem India in the European market.

Key Highlights

  • Sale of formulations manufacturing facility for Rs. 36.90 crores
  • No impact on company's business as products can be manufactured in other facilities
  • Acquisition of 100% share capital of Unichem Laboratories Ltd., Ireland for Rs. 4 Crores
  • Unichem Ireland holds registration of formulation product dossiers in Europe
IPCALAB
Pharmaceuticals
IPCA LABORATORIES LTD.

Price Impact